{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T10:30:21Z","timestamp":1793788221332,"version":"4.6.1"},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T00:00:00Z","timestamp":1780963200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jhltopen.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JHLT Open"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.jhlto.2026.100610","type":"journal-article","created":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T00:01:23Z","timestamp":1784678483000},"page":"100610","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Efficacy and safety of everolimus in heart transplant recipients: A meta-analysis"],"prefix":"10.1016","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7706-6599","authenticated-orcid":false,"given":"Sofia Helena","family":"Vitte","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio Medina","family":"Luna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia Jersak","family":"Pille","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6797-418X","authenticated-orcid":false,"given":"Bruno Naz\u00e1rio","family":"Pinheiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcella Baggio Lopes de","family":"Souza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clariphen Debbie Joseph","family":"Irudhayaraj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giancarlo Maruri","family":"Munaretto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.jhlto.2026.100610_bib1","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.trre.2015.02.005","article-title":"Immunosuppressive therapies after heart transplantation--The balance between under- and over-immunosuppression","volume":"29","author":"S\u00f6derlund","year":"2015","journal-title":"Transplant Rev Orlando Fla"},{"issue":"1","key":"10.1016\/j.jhlto.2026.100610_bib2","article-title":"An overview of the efficacy and safety of everolimus in adult solid organ transplant recipients","volume":"36","author":"Tedesco-Silva","year":"2022","journal-title":"Transplant Rev Orlando Fla"},{"issue":"9","key":"10.1016\/j.jhlto.2026.100610_bib3","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.117.004050","article-title":"Effect of everolimus initiation and calcineurin inhibitor elimination on cardiac allograft vasculopathy in De Novo heart transplant recipients","volume":"11","author":"Arora","year":"2018","journal-title":"Circ Heart Fail"},{"issue":"4","key":"10.1016\/j.jhlto.2026.100610_bib4","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1136\/ebmental-2019-300117","article-title":"How to perform a meta-analysis with R: a practical tutorial","volume":"22","author":"Balduzzi","year":"2019","journal-title":"Evid Based Ment Health"},{"issue":"5","key":"10.1016\/j.jhlto.2026.100610_bib5","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1111\/ajt.12208","article-title":"Differential effect of everolimus on progression of early and late cardiac allograft vasculopathy in current clinical practice","volume":"13","author":"Masetti","year":"2013","journal-title":"Am J Transplant"},{"issue":"10","key":"10.1016\/j.jhlto.2026.100610_bib6","first-page":"3333","article-title":"Everolimus in heart transplantation: initial experience in Taiwan","volume":"39","author":"Chou","year":"2007","journal-title":"Transplant Proc"},{"issue":"suppl_1","key":"10.1016\/j.jhlto.2026.100610_bib7","article-title":"Effects of everolimus conversion from mycophenolate mofetil on cardiac allograft vasculopathy in heart transplant recipients","volume":"34","author":"Watanabe","year":"2013","journal-title":"Eur Heart J"},{"issue":"4","key":"10.1016\/j.jhlto.2026.100610_bib8","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.jjcc.2014.12.010","article-title":"Neutrophil gelatinase-associated lipocalin (NGAL) in heart transplant recipients after conversion to everolimus therapy","volume":"66","author":"Stypmann","year":"2015","journal-title":"J Cardiol"},{"issue":"1","key":"10.1016\/j.jhlto.2026.100610_bib9","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.trim.2006.02.001","article-title":"Everolimus and reduced cyclosporine trough levels in maintenance heart transplant recipients","volume":"16","author":"Schweiger","year":"2006","journal-title":"Transpl Immunol"},{"issue":"15","key":"10.1016\/j.jhlto.2026.100610_bib10","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1001\/jama.2025.14338","article-title":"Everolimus and low-dose tacrolimus after heart transplant in children: a randomized clinical trial","volume":"334","author":"Almond","year":"2025","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.jhlto.2026.100610_bib11","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1111\/ajt.12181","article-title":"Everolimus versus mycophenolate mofetil in heart transplantation: a randomized, multicenter trial","volume":"13","author":"Eisen","year":"2013","journal-title":"Am J Transplant Off J Am Soc Transplant Am Soc Transpl Surg"},{"issue":"6","key":"10.1016\/j.jhlto.2026.100610_bib12","doi-asserted-by":"crossref","first-page":"S379","DOI":"10.1016\/S1769-7255(09)73429-7","article-title":"[Benefits of proliferation signal inhibitors beyond immunosuppression. Vascular protection and experience in heart transplantation]","volume":"5","author":"Caillard","year":"2009","journal-title":"Nephrol Ther"},{"issue":"3","key":"10.1016\/j.jhlto.2026.100610_bib13","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/j.transproceed.2010.03.002","article-title":"The survival of heart transplant recipients using cyclosporine and everolimus is not inferior to that using cyclosporine and mycophenolate","volume":"42","author":"Wang","year":"2010","journal-title":"Transplant Proc"},{"issue":"3","key":"10.1016\/j.jhlto.2026.100610_bib14","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.trre.2013.03.002","article-title":"Everolimus immunosuppression in de novo heart transplant recipients: what does the evidence tell us now?","volume":"27","author":"Zuckermann","year":"2013","journal-title":"Transplant Rev Orlando Fla"},{"issue":"7","key":"10.1016\/j.jhlto.2026.100610_bib15","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1097\/TP.0b013e3181cbac2d","article-title":"Everolimus with reduced calcineurin inhibitor in thoracic transplant recipients with renal dysfunction: a multicenter, randomized trial","volume":"89","author":"Gullestad","year":"2010","journal-title":"Transplantation"},{"issue":"1","key":"10.1016\/j.jhlto.2026.100610_bib16","article-title":"Everolimus in heart transplantation: an update","volume":"2013","author":"Hirt","year":"2013","journal-title":"J Transplant"},{"issue":"3","key":"10.1016\/j.jhlto.2026.100610_bib17","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.trre.2010.01.005","article-title":"Clinical recommendations for the use of everolimus in heart transplantation","volume":"24","author":"Manito","year":"2010","journal-title":"Transplant Rev Orlando Fla"},{"key":"10.1016\/j.jhlto.2026.100610_bib18","article-title":"Impact of everolimus initiation and corticosteroid weaning during acute phase after heart transplantation on clinical outcome: data from the Korean Organ Transplant Registry (KOTRY)","volume":"37","author":"Lee","year":"2024","journal-title":"Transpl Int Off J Eur Soc Organ Transplant"},{"issue":"8","key":"10.1016\/j.jhlto.2026.100610_bib19","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1111\/ajt.12809","article-title":"Everolimus initiation and early calcineurin inhibitor withdrawal in heart transplant recipients: a randomized trial","volume":"14","author":"Andreassen","year":"2014","journal-title":"Am J Transplant Off J Am Soc Transplant Am Soc Transpl Surg"},{"key":"10.1016\/j.jhlto.2026.100610_bib20","doi-asserted-by":"crossref","DOI":"10.1111\/ajt.15361","article-title":"Comparing everolimus-based immunosuppression with reduction or withdrawal of calcineurin inhibitor reduction from six months after heart transplantation: the randomized MANDELA study","author":"Barten","year":"2019","journal-title":"Am J Transplant Off J Am Soc Transplant Am Soc Transpl Surg"}],"container-title":["JHLT Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S295013342600131X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S295013342600131X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T10:12:57Z","timestamp":1793787177000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S295013342600131X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":20,"alternative-id":["S295013342600131X"],"URL":"https:\/\/doi.org\/10.1016\/j.jhlto.2026.100610","relation":{},"ISSN":["2950-1334"],"issn-type":[{"value":"2950-1334","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy and safety of everolimus in heart transplant recipients: A meta-analysis","name":"articletitle","label":"Article Title"},{"value":"JHLT Open","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhlto.2026.100610","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of International Society for Heart and Lung Transplantation.","name":"copyright","label":"Copyright"}],"article-number":"100610"}}